<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39411663</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2732-494X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Antimicrobial stewardship &amp; healthcare epidemiology : ASHE</Title><ISOAbbreviation>Antimicrob Steward Healthc Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Derivation of a risk-adjusted model to predict antibiotic prescribing among hospitalists in an academic healthcare network.</ArticleTitle><Pagination><StartPage>e163</StartPage><MedlinePgn>e163</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/ash.2024.422</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Among inpatients, peer-comparison of prescribing metrics is challenging due to variation in patient-mix and prescribing by multiple providers daily. We established risk-adjusted provider-specific antibiotic prescribing metrics to allow peer-comparisons among hospitalists.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using clinical and billing data from inpatient encounters discharged from the Hospital Medicine Service between January 2020 through June 2021 at four acute care hospitals, we calculated bimonthly (every two months) days of therapy (DOT) for antibiotics attributed to specific providers based on patient billing dates. Ten patient-mix characteristics, including demographics, infectious disease diagnoses, and noninfectious comorbidities were considered as potential predictors of antibiotic prescribing. Using linear mixed models, we identified risk-adjusted models predicting the prescribing of three antibiotic groups: broad spectrum hospital-onset (BSHO), broad-spectrum community-acquired (BSCA), and anti-methicillin-resistant Staphylococcus aureus (Anti-MRSA) antibiotics. Provider-specific observed-to-expected ratios (OERs) were calculated to describe provider-level antibiotic prescribing trends over time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Predictors of antibiotic prescribing varied for the three antibiotic groups across the four hospitals, commonly selected predictors included sepsis, COVID-19, pneumonia, urinary tract infection, malignancy, and age &gt;65 years. OERs varied within each hospital, with medians of approximately 1 and a 75th percentile of approximately 1.25. The median OER demonstrated a downward trend for the Anti-MRSA group at two hospitals but remained relatively stable elsewhere. Instances of heightened antibiotic prescribing (OER &gt;1.25) were identified in approximately 25% of the observed time-points across all four hospitals.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our findings indicate provider-specific benchmarking among inpatient providers is achievable and has potential utility as a valuable tool for inpatient stewardship efforts.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Onwubiko</LastName><ForeName>Udodirim N</ForeName><Initials>UN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Zanthia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Jesse T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0001-9811-6260</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashley Jones</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Emory Healthcare, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubes</LastName><ForeName>Julianne</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6717-3104</Identifier><AffiliationInfo><Affiliation>Office of Quality, Emory Healthcare, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabbir</LastName><ForeName>Hasan F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Quality, Emory Healthcare, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchindran</LastName><ForeName>Sujit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fridkin</LastName><ForeName>Scott K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0003-4892-693X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Steward Healthc Epidemiol</MedlineTA><NlmUniqueID>9918266096106676</NlmUniqueID><ISSNLinking>2732-494X</ISSNLinking></MedlineJournalInfo><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411663</ArticleId><ArticleId IdType="pmc">PMC11474874</ArticleId><ArticleId IdType="doi">10.1017/ash.2024.422</ArticleId><ArticleId IdType="pii">S2732494X24004224</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019; 2019. Available from: 10.15620/cdc:82532. Accessed May, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:82532</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorpe KE, Joski P, Johnston KJ. Antibiotic-resistant infection treatment costs have doubled since 2002, Now exceeding $2 billion annually. Health Aff (Millwood) 2018;37:662–9. doi: 10.1377/hlthaff.2017.1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2017.1153</ArticleId><ArticleId IdType="pubmed">29561692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm Therap 2015;40:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4378521</ArticleId><ArticleId IdType="pubmed">25859123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson RE, Hyun D, Jezek A, Samore MH. Mortality, length of stay, and healthcare costs associated with multidrug-resistant bacterial infections among elderly hospitalized patients in the United States. Clin Infect Dis 2022;74:1070–80. doi: 10.1093/cid/ciab696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab696</ArticleId><ArticleId IdType="pmc">PMC8946701</ArticleId><ArticleId IdType="pubmed">34617118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jit M, Ng DHL, Luangasanatip N., et al. Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies. BMC Med 2020;18:1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059710</ArticleId><ArticleId IdType="pubmed">32138748</ArticleId></ArticleIdList></Reference><Reference><Citation>Magill SS, O’Leary E, Ray SM, et al. Assessment of the appropriateness of antimicrobial use in US Hospitals. JAMA Netw Open 2021;4:e212007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974639</ArticleId><ArticleId IdType="pubmed">33734417</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med. 2016;176:1639–48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10863902</ArticleId><ArticleId IdType="pubmed">27653796</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC. 2021 National Healthcare Safety Network Antimicrobial Use Option Report. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/nhsn/pdfs/datastat/2021-AU-Report-508.pdf
</Citation></Reference><Reference><Citation>Goodman KE, Cosgrove SE, Pineles L, et al. Significant regional differences in antibiotic use across 576 US hospitals and 11 701 326 adult admissions, 2016-2017. Clin Infect Dis 2021;73:213–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282314</ArticleId><ArticleId IdType="pubmed">32421195</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis 2014;58:401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4645276</ArticleId><ArticleId IdType="pubmed">24162744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu KC, Moisan E, Tartof SY, et al. Benchmarking inpatient antimicrobial use: a comparison of risk-adjusted observed-to-expected ratios. Clini Infect Dis 2018;67:1677–85. doi: 10.1093/cid/ciy354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy354</ArticleId><ArticleId IdType="pubmed">29688279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridkin SK. The fog may be lifting around antibiotic use metrics and interfacility comparison. Clin Infect Dis 2018;67:1686–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29688288</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan BL, Bettencourt H, May L. Interrupted time-series analysis to evaluate the impact of a behavioral change outpatient antibiotic stewardship intervention. Antimicrob Steward Healthc Epidemiol 2021;1:e37. doi: 10.1017/ash.2021.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2021.203</ArticleId><ArticleId IdType="pmc">PMC9495536</ArticleId><ArticleId IdType="pubmed">36168485</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneman N, Lee SM, Bai H, et al. Population-wide peer comparison audit and feedback to reduce antibiotic initiation and duration in long-term care facilities with embedded randomized controlled trial. Clin Infect Dis 2021;73:e1296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8442778</ArticleId><ArticleId IdType="pubmed">33754632</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneman N, Lee S, Bai H, et al. Behavioral Nudges to Improve Audit and Feedback Report Opening Among Antibiotic Prescribers: A Randomized Controlled Trial. Open Forum Infect Dis 2022;9:ofac111. doi: 10.1093/ofid/ofac111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac111</ArticleId><ArticleId IdType="pmc">PMC8982784</ArticleId><ArticleId IdType="pubmed">35392461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronman MP, Gerber JS, Grundmeier RW, et al. Reducing antibiotic prescribing in primary care for respiratory illness. Pediatrics 2020;146:e20200038. doi: 10.1542/peds.2020-0038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0038</ArticleId><ArticleId IdType="pmc">PMC7461202</ArticleId><ArticleId IdType="pubmed">32747473</ArticleId></ArticleIdList></Reference><Reference><Citation>Newland JG, Banerjee R, Gerber JS, Hersh AL, Steinke L, Weissman SJ. Antimicrobial stewardship in pediatric care: Strategies and future directions. Pharmacotherapy 2012;32:735–43. doi: 10.1002/j.1875-9114.2012.01155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1875-9114.2012.01155.x</ArticleId><ArticleId IdType="pubmed">23307521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung S, Sexton ME, Owens S, Spell N, Fridkin S. Variability of antibiotic prescribing in a large healthcare network despite adjusting for patient-mix: reconsidering targets for improved prescribing. Open Forum Infect Dis 2019;6:ofz018. doi: 10.1093/ofid/ofz018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz018</ArticleId><ArticleId IdType="pmc">PMC6386112</ArticleId><ArticleId IdType="pubmed">30815500</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288–94.</Citation><ArticleIdList><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG. Bootstrap investigation of the stability of a cox regression model. Stat Med 1989;8:771–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">2672226</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinze G, Wallisch C, Dunkler D. Variable selection – a review and recommendations for the practicing statistician. Biometric J 2018;60:431–49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969114</ArticleId><ArticleId IdType="pubmed">29292533</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers ND, Brincks AM, Ames AJ, Prado GJ, Penedo FJ, Benedict C. Multilevel modeling in psychosomatic medicine research. Psychosom Med 2012;74:925–36. doi: 10.1097/PSY.0b013e3182736971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e3182736971</ArticleId><ArticleId IdType="pmc">PMC3498540</ArticleId><ArticleId IdType="pubmed">23107843</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Leckie G. Bootstrapped inference for variance parameters, measures of heterogeneity and random effects in multilevel logistic regression models. J Stat Comput Simul 2020;90:3175–99.</Citation></Reference><Reference><Citation>Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8668867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba K, Shinozaki T, Maruo K, Noma H. Re-evaluation of the comparative effectiveness of bootstrap-based optimism correction methods in the development of multivariable clinical prediction models. BMC Med Res Methodol 2021;21:1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789544</ArticleId><ArticleId IdType="pubmed">33413132</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GCS, Seaman SR, Wood AM, Royston P, White IR. Correcting for Optimistic Prediction in Small Data Sets. Am J Epidemiol. 2014;180:318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108045</ArticleId><ArticleId IdType="pubmed">24966219</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller S, Scealy JL, Welsh AH. Model selection in linear mixed models. Statist Sci 2013;28:135–67. doi: 10.1214/12-STS410</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/12-STS410</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, Lu Y. Model selection in linear mixed effect models. J Multivar Anal 2012;109:109–29.</Citation></Reference><Reference><Citation>Vaida F, Blanchard S. Conditional Akaike information for mixed-effects models. Biometrika 2005;92:351–70.</Citation></Reference><Reference><Citation>Säfken B, Rügamer D, Kneib T, Greven S. Conditional Model Selection in Mixed-Effects Models with cAIC4. J Stat Softw 2021;99:1–30.</Citation></Reference><Reference><Citation>Smith GCS, Seaman SR, Wood AM, Royston P, White IR. Correcting for Optimistic Prediction in Small Data Sets. Am J Epidemiol 2014;180:318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108045</ArticleId><ArticleId IdType="pubmed">24966219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanescu AE, Li P, George B, et al. The Importance of Prediction Model Validation and Assessment in Obesity and Nutrition Research. Int J Obes (Lond) 2016;40:887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4826636</ArticleId><ArticleId IdType="pubmed">26449421</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>